C09,C10,C12-C14 -Malignant neoplasm of other sites in the pharynx
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C09,C10,C12-C14 – N =12,095
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1982 | 5.7% | 14.3% | 25% | 42.9% | 12.1% | 140 |
1983 | 9.9% | 16.7% | 24.7% | 43.2% | 5.6% | 162 |
1984 | 10.4% | 12% | 26.2% | 44.8% | 6.6% | 183 |
1985 | 7.8% | 11.1% | 23.9% | 52.2% | 5% | 180 |
1986 | 5.7% | 10.4% | 28.1% | 48.4% | 7.3% | 192 |
1987 | 13.4% | 12% | 26.7% | 38.2% | 9.7% | 217 |
1988 | 7.5% | 11% | 18% | 55.7% | 7.9% | 228 |
1989 | 3.5% | 15.2% | 27.7% | 47.2% | 6.5% | 231 |
1990 | 9.4% | 7.2% | 24.3% | 51.1% | 8.1% | 235 |
1991 | 3.3% | 12.4% | 30.3% | 43.6% | 10.4% | 241 |
1992 | 6.7% | 10% | 23.4% | 50.2% | 9.6% | 239 |
1993 | 5.9% | 9.4% | 22.7% | 50.6% | 11.4% | 255 |
1994 | 8% | 9.3% | 22.6% | 47.8% | 12.3% | 301 |
1995 | 4.7% | 6.1% | 13.7% | 55.4% | 20.1% | 278 |
1996 | 6.9% | 7.5% | 18.3% | 53.9% | 13.4% | 306 |
1997 | 2.6% | 6.3% | 16.4% | 59.2% | 15.5% | 348 |
1998 | 4.9% | 6.4% | 18.3% | 53.9% | 16.5% | 345 |
1999 | 4% | 8% | 19.6% | 51.2% | 17.2% | 377 |
2000 | 4% | 9.3% | 16.6% | 55.4% | 14.6% | 397 |
2001 | 4.9% | 6.7% | 16.3% | 55.6% | 16.5% | 430 |
2002 | 4.5% | 6.2% | 17.5% | 56.4% | 15.5% | 401 |
2003 | 3.7% | 7.4% | 17.4% | 57.7% | 13.9% | 461 |
2004 | 5.5% | 7.7% | 19.1% | 55.2% | 12.5% | 455 |
2005 | 3.6% | 6.9% | 16.5% | 52.2% | 20.8% | 504 |
2006 | 4.5% | 8.2% | 14.7% | 62.1% | 10.6% | 464 |
2007 | 6.8% | 6.1% | 21.5% | 55.7% | 9.9% | 526 |
2008 | 4.3% | 6.5% | 19.2% | 59% | 11% | 537 |
2009 | 5.1% | 5.9% | 16.8% | 65.6% | 6.6% | 547 |
2010 | 5.5% | 5.9% | 17.6% | 63.3% | 7.8% | 529 |
2011 | 4.7% | 6.9% | 13.8% | 67.3% | 7.3% | 551 |
2012 | 4.7% | 6.5% | 15% | 61.8% | 12% | 615 |
2013 | 5.3% | 7.3% | 17.1% | 61.2% | 9.1% | 626 |
2014 | 4.4% | 6.1% | 17.8% | 63% | 8.8% | 594 |